Finance

Beta
Lists
2796:TYO
Pharmarise Holdings Corp
Â¥473.00
+0.21%
(+1.00) 1D
Jul 2, 10:05:52 AM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2796...
Open
Â¥473
High
Â¥476
Low
Â¥471
Mkt. cap
5.70B
Avg. vol.
13.62K
Volume
5.00K
Dividend
2.96%
Quarterly dividend
Â¥3
Ex-dividend date
May 28, 2026
P/E ratio
49.17
52-wk high
Â¥558
52-wk low
Â¥471
EPS
Â¥10
Shares outstanding
9.24M
No. of employees
2K
Open
Â¥473
High
Â¥476
Low
Â¥471
Mkt. cap
5.70B
Avg. vol.
13.62K
Volume
5.00K
Dividend
2.96%
Quarterly dividend
Â¥3
Ex-dividend date
May 28, 2026
P/E ratio
49.17
52-wk high
Â¥558
52-wk low
Â¥471
EPS
Â¥10
Shares outstanding
9.24M
No. of employees
2K
News stories
From sources across the web
About Pharmarise Holdings Corp
CEOToshimichi Ohno
Employees2.04K
FoundedJun 28, 1984
Headquarters-
SectorDrug
Websitepharmarise.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
16.75B
16.85B
16.95B
18.96B
Cost of goods sold
14.52B
14.53B
14.60B
16.41B
Cost of revenue
14.52B
14.53B
14.60B
16.41B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.08B
2.08B
2.17B
2.15B
Operating expense
2.08B
2.05B
2.20B
2.13B
Total operating expenses
16.60B
16.58B
16.80B
18.53B
Operating income
153.00M
273.00M
159.00M
422.00M
Other non operating income
21.00M
25.00M
-30.00M
-8.00M
EBT including unusual items
132.00M
236.00M
67.00M
264.00M
EBT excluding unusual items
116.00M
239.00M
64.00M
324.00M
Income tax expense
153.00M
108.00M
193.00M
137.00M
Effective tax rate
115.91%
45.76%
-
51.89%
Other operating expenses
-
-
-
-
Net income
-18.00M
129.00M
-124.00M
127.00M
Net profit margin
-0.11%
0.77%
-
0.67%
Earnings per share
-
-
-
-
Interest and investment income
3.00M
3.00M
4.00M
3.00M
Interest expense
-61.00M
-62.00M
-69.00M
-93.00M
Net interest expenses
-58.00M
-59.00M
-65.00M
-90.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
526.25M
656.00M
532.25M
823.25M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer